These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31387886)

  • 1. A Step-Wedge in the Biochemical Diagnosis of Preeclampsia.
    Lemoine ER; Karumanchi SA
    Clin Chem; 2019 Nov; 65(11):1348-1349. PubMed ID: 31387886
    [No Abstract]   [Full Text] [Related]  

  • 2. PROGNOSIS looking good for a possible serum test for preeclampsia.
    Dowdall M
    Future Cardiol; 2014 Mar; 10(2):164-5. PubMed ID: 24883442
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary sFlt-1 and PlGF levels are strongly correlated to serum sFlt-1/PlGF ratio and serum PlGF in women with preeclampsia.
    Hebert-Schuster M; Ranaweera T; Fraichard C; Gaudet-Chardonnet A; Tsatsaris V; Guibourdenche J; Lecarpentier E
    Pregnancy Hypertens; 2018 Apr; 12():82-83. PubMed ID: 29674205
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological variation of two serum markers for preeclampsia prediction.
    Braga F; Ferraro S; Borille S; Panteghini M
    Clin Chem Lab Med; 2020 Jan; 58(2):e27-e28. PubMed ID: 31377736
    [No Abstract]   [Full Text] [Related]  

  • 5. Performance of soluble fms-like tyrosine kinase-1-to-placental growth factor ratio of ≥85 for ruling in preeclampsia within 4 weeks.
    Cerdeira AS; O'Sullivan J; Ohuma EO; James T; Papageorghiou AT; Knight M; Vatish M
    Am J Obstet Gynecol; 2021 Mar; 224(3):322-323. PubMed ID: 33207235
    [No Abstract]   [Full Text] [Related]  

  • 6. Placental growth factor: A review of literature and future applications.
    Hayes Ryan D; McCarthy FP; O'Donoghue K; Kenny LC
    Pregnancy Hypertens; 2018 Oct; 14():260-264. PubMed ID: 29555222
    [No Abstract]   [Full Text] [Related]  

  • 7. [What place for the biomarkers of preeclampsia?].
    Tsatsaris V
    Gynecol Obstet Fertil Senol; 2017; 45(7-8):385-386. PubMed ID: 28784350
    [No Abstract]   [Full Text] [Related]  

  • 8. [Angiogenic factors can be used when pre-eclampsia is suspected].
    Andrea MK; Lykke JA
    Ugeskr Laeger; 2015 May; 177(22):V11140638. PubMed ID: 26027672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental growth factor (PlGF) and sFlt-1 during pregnancy: physiology, assay and interest in preeclampsia.
    Lecarpentier É; Vieillefosse S; Haddad B; Fournier T; Leguy MC; Guibourdenche J; Tsatsaris V
    Ann Biol Clin (Paris); 2016 Jun; 74(3):259-67. PubMed ID: 27237799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of sFlt-1/PlGF ratio in preeclampsia : a monocentric retrospective analysis].
    Verbeurgt L; Chantraine F; De Marchin J; Minon JM; Nisolle M
    Rev Med Liege; 2017 Sep; 72(9):393-398. PubMed ID: 28892314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two new blood tests will help doctors rule out pre-eclampsia, says NICE.
    Wise J
    BMJ; 2016 May; 353():i2690. PubMed ID: 27179016
    [No Abstract]   [Full Text] [Related]  

  • 12. The Use of Soluble FMS-like Tyrosine Kinase 1/Placental Growth Factor Ratio in the Clinical Management of Pre-eclampsia.
    Govender N; Moodley J; Naicker T
    Afr J Reprod Health; 2018 Dec; 22(4):135-143. PubMed ID: 30632730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating angiogenic factors and preeclampsia.
    Tsatsaris V; Goffin F; Foidart JM
    N Engl J Med; 2004 May; 350(19):2003-4; author reply 2003-4. PubMed ID: 15128904
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarker Immunoassays in the Diagnosis of Preeclampsia: Calculating the sFlt1/PlGF Ratio Using the Cobas
    Black C; da Silva Costa F
    Methods Mol Biol; 2018; 1710():9-26. PubMed ID: 29196991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive and prognostic factors of preeclampsia: Interest of PlGF and sFLT-1].
    Vieillefosse S; Guibourdenche J; Atallah A; Haddad B; Fournier T; Tsatsaris V; Lecarpentier E
    J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):999-1008. PubMed ID: 27212611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns.
    Portelli M; Baron B
    J Pregnancy; 2018; 2018():2632637. PubMed ID: 30050697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of the concetrations ratio of soluble receptor tyrosine kinase type 1, and placental growth factor for short-term prediction and diagnosis of preeclampsia].
    Bubeníková Š; Cíchová A; Roubalová L; Durdová V; Vlk R
    Ceska Gynekol; 2016; 81(4):272-278. PubMed ID: 27882748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble fms-like tyrosine kinase-1 and placental growth factor in Chinese pregnant women during second and third trimesters.
    Cheng YK; Law LW; Leung TY; Chan OK; Sahota DS
    Hong Kong Med J; 2018 Jun; 24 Suppl 3(3):45-47. PubMed ID: 29937448
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia: INSPIRE.
    Cerdeira AS; O'Sullivan J; Ohuma EO; Harrington D; Szafranski P; Black R; Mackillop L; Impey L; Greenwood C; James T; Smith I; Papageorghiou AT; Knight M; Vatish M
    Hypertension; 2019 Oct; 74(4):983-990. PubMed ID: 31401877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An updated view on the origin and use of angiogenic biomarkers for preeclampsia.
    Huppertz B
    Expert Rev Mol Diagn; 2018 Dec; 18(12):1053-1061. PubMed ID: 30413130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.